Multidrug resistance (MDR) expression in chronic myelogenous leukemia (CML).

被引：0
|
作者：
Kantarjian, H [1 ]
Manshouri, T [1 ]
Talpaz, M [1 ]
OBrien, S [1 ]
Keating, M [1 ]
Cortes, J [1 ]
Pierce, S [1 ]
Andreeff, M [1 ]
Kornblau, S [1 ]
Albitar, M [1 ]
机构：
[1] UNIV TEXAS,MD ANDERSON CANCER CTR,HOUSTON,TX 77030
来源：
BLOOD | 1997年 / 90卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2236 / 2236
页数：1
相关论文
共 50 条
  • [31] TRANSPLANTATION REGIMENS FOR CHRONIC MYELOGENOUS LEUKEMIA (CML) IN CHRONIC PHASE (CP)
    CLIFT, RA
    BUCKNER, CD
    STORB, R
    THOMAS, ED
    EXPERIMENTAL HEMATOLOGY, 1988, 16 (06) : 501 - 501
  • [32] Monitoring imatinib resistance with a "Polony" assay: Towards tailored therapy of chronic myelogenous leukemia (CML).
    Nardi, Valentina
    Raz, Tal
    Chao, Xinyu
    Wu, Catherine J.
    Stone, Richard
    Galinsky, Ilene
    Wadleigh, Martha
    Deininger, Michael W. N.
    Church, George
    Zhu, Jun
    Daley, George Q.
    BLOOD, 2006, 108 (11) : 251A - 252A
  • [33] THE CLINICAL SIGNIFICANCE OF MULTIDRUG RESISTANCE GENE(mdr1) EXPRESSION IN ACUTE LEUKEMIA
    董作仁
    罗建民
    徐文新
    王福旭
    郭晓楠
    张学军
    姚尔固
    徐世荣
    任金海
    丛斌
    ChineseJournalofCancerResearch, 1998, (01) : 61 - 64
  • [34] ATTEMPT TO INDUCE TRUE REMISSION IN CHRONIC MYELOGENOUS LEUKEMIA (CML)
    DOWLING, MD
    HOPFAN, S
    KNAPPER, WH
    VAARTAJA, T
    GEE, T
    HAGHBIN, M
    CLARKSON, BD
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1974, 15 (MAR): : 189 - 189
  • [35] Implications of Bim in abnormal hematopoiesis of chronic myelogenous leukemia (CML).
    Kuribara, R
    Honda, H
    Shinjyo, TA
    Hirai, H
    Ozawa, K
    Inaba, T
    BLOOD, 2001, 98 (11) : 467A - 467A
  • [36] PROGNOSTIC FACTORS IN DIFFERENT STAGES OF CHRONIC MYELOGENOUS LEUKEMIA (CML)
    KANTARJIAN, HM
    LEUKEMIA, 1987, 1 (03) : 255 - 255
  • [37] INCREASED RISK OF ACUTE MYELOGENOUS LEUKEMIA (AML) AND CHRONIC MYELOGENOUS LEUKEMIA (CML) IN A COUNTY OF HESSE, GERMANY
    KOLB, G
    BECKER, N
    SCHELLER, S
    ZUGMAIER, G
    PRALLE, H
    WAHRENDORF, J
    HAVEMANN, K
    SOZIAL-UND PRAVENTIVMEDIZIN, 1993, 38 (04): : 190 - 195
  • [38] CHRONIC MYELOGENOUS LEUKEMIA (CML) DEVELOPING AFTER THYMIC IRRADIATION
    SHIMAOKA, K
    SOKAL, JE
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1974, 15 (MAR): : 131 - 131
  • [39] CHRONIC MYELOGENOUS LEUKEMIA (CML) PRESENTING WITH LYMPHOBLASTIC-CONVERSION
    CRIST, WM
    RAGAB, AH
    DUCOS, R
    LAWTON, AR
    SHEARER, WT
    PEDIATRIC RESEARCH, 1976, 10 (04) : 375 - 375
  • [40] Development of a curative treatment program for chronic myelogenous leukemia (CML).
    Clarkson, B
    Veach, D
    Bornmann, WG
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U434 - U434
12345